Published by Josh White on 26th May 2023
(Sharecast News) - Hutchmed China, in collaboration with Takeda, announced on Friday that the US Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) of fruquintinib.
URL: http://www.digitallook.com/dl/news/story/33532024/...